Microdosing Ozempic The New Weight Loss Trend That Raises Eyebrows and Concerns

The New York Times article discusses the rising trend of "microdosing" the weight loss drug Ozempic, where individuals take significantly lower doses to minimize side effects while still aiming for weight loss. Patients like psychologist Erica Liebman and others report success in managing their weight and reducing side effects through microdosing, despite the lack of strong scientific evidence supporting this practice. Promoters of microdosing, including health influencers, advocate for this method on social media, leading to increased consumer interest. However, medical professionals caution that the long-term effects and efficacy of microdosing remain uncertain, highlighting concerns about potential risks when done without medical supervision.

Key Points:

• Microdosing involves taking very small amounts of weight loss medications like Ozempic.
• Many individuals are attracted to microdosing to avoid severe side effects such as nausea and vomiting.
• Health influencers are promoting microdosing for various conditions and weight loss, despite limited evidence.
• Doctors express doubts about the effectiveness of microdosing and urge caution, highlighting the potential for placebo effects.
• Patients report lifestyle changes and weight loss success with microdosing, but the lack of professional guidance raises concerns.
• The use of compounded versions of weight loss drugs without FDA oversight is another health risk linked to microdosing trends.
  Link to Article